XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.3Close
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:              
Net earnings $ (93) $ 1,879 $ 1,569 $ 1,188 $ 3,541 $ 4,391  
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities              
Change in receivables and advance premiums         28 42  
Capitalization of deferred policy acquisition costs         (767) (804)  
Amortization of deferred policy acquisition costs 214   201   638 608 $ 816
Increase in policy liabilities         (259) (99)  
Change in income tax liabilities         (64) (289)  
Net investment (gains) losses 1,408   (423)   (239) (1,101)  
Other, net         (504) (140)  
Net cash provided (used) by operating activities         2,374 2,608   Close
Proceeds from investments sold or matured:              
Available-for-sale fixed maturity securities         4,832 2,112  
Equity securities         702 353  
Held-to-maturity fixed maturity securities         2 2  
Commercial mortgage and other loans         1,482 1,276  
Costs of investments acquired:              
Available-for-sale fixed maturity securities         (4,589) (2,359)  
Equity securities         (333) (299)  
Commercial mortgage and other loans         (937) (744)  
Other investments, net         (2,682) (1,153)  
Settlement of derivatives, net         (92) 56  
Cash received (pledged or returned) as collateral, net         2,781 2,894  
Other, net         98 (160)  
Net cash provided (used) by investing activities         1,264 1,978   Close
Cash flows from financing activities:              
Purchases of treasury stock         (2,050) (2,100)  
Proceeds from borrowings         823 0  
Principal payments under debt obligations         (194) 0  
Dividends paid to shareholders         (820) (730)  
Change in investment-type contracts, net         (162) (114)  
Treasury stock reissued         21 9  
Other, net         (20) (1)  
Net cash provided (used) by financing activities         (2,402) (2,936)   Close
Effect of exchange rate changes on cash and cash equivalents         70 (91)   Close
Net change in cash and cash equivalents         1,306 1,559   Close
Cash and cash equivalents, beginning of period   $ 4,306   $ 3,943 4,306 3,943 3,943
Cash and cash equivalents, end of period $ 5,612   $ 5,502   5,612 5,502 $ 4,306
Supplemental disclosures of cash flow information:              
Income taxes paid         805 870  
Interest paid         127 132  
Noncash interest         21 16  
Noncash real estate acquired in satisfaction of debt         380 90  
Noncash financing activities:              
Lease obligations         25 50  
Associate stock bonus              
Treasury stock issued for:              
Treasury stock issued         15 13  
Shareholder dividend reinvestment              
Treasury stock issued for:              
Treasury stock issued         31 28  
Share-based compensation grants              
Treasury stock issued for:              
Treasury stock issued         $ 6 $ 5